Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer.

NCT04738019 is registered in ClinicalTrials.gov with LG Chem as lead sponsor.

NCT NCT04738019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04738019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective Observational Study to Evaluate the Incidence of Delayed-onset Nodules of YVOIRE Y-Solution 360, YVOIRE Y-Solution 540 or YVOIRE Y-Solution 720 Injected Into the Facial Skin Layer.
Lead sponsor
LG Chem
Phase
Observational
Overall status
Completed
Start date
June 18, 2020
Completion date
February 28, 2022
Enrollment
1,022 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy condition